Format

Send to

Choose Destination
J Nucl Cardiol. 2009 May-Jun;16(3):478-80. doi: 10.1007/s12350-008-9043-z. Epub 2009 Jan 22.

Initial clinical experience with a selective A2A receptor agonist, regadenoson, in a patient with end-stage renal disease on hemodialysis.

Author information

1
Division of Cardiology, North Shore University Hospital, Manhasset, USA.
PMID:
19159989
DOI:
10.1007/s12350-008-9043-z
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center